CAD 0.04
(-20.0%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | - CAD | 0.0% |
2022 | - CAD | 0.0% |
2021 | - CAD | 0.0% |
2020 | - CAD | 0.0% |
2019 | - CAD | 0.0% |
2018 | - CAD | 0.0% |
2017 | - CAD | 0.0% |
2016 | - CAD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | - CAD | 0.0% |
2023 Q3 | - CAD | 0.0% |
2023 FY | - CAD | 0.0% |
2023 Q1 | - CAD | 0.0% |
2023 Q2 | - CAD | 0.0% |
2023 Q4 | - CAD | 0.0% |
2022 Q2 | - CAD | 0.0% |
2022 Q1 | - CAD | -100.0% |
2022 FY | - CAD | 0.0% |
2022 Q4 | - CAD | 0.0% |
2022 Q3 | - CAD | 0.0% |
2021 Q2 | - CAD | 0.0% |
2021 Q3 | - CAD | 0.0% |
2021 Q4 | 38.61 CAD | 0.0% |
2021 FY | - CAD | 0.0% |
2021 Q1 | - CAD | 0.0% |
2020 Q2 | - CAD | 0.0% |
2020 FY | - CAD | 0.0% |
2020 Q4 | - CAD | 0.0% |
2020 Q3 | - CAD | 0.0% |
2020 Q1 | - CAD | 0.0% |
2019 Q2 | - CAD | 0.0% |
2019 FY | - CAD | 0.0% |
2019 Q4 | - CAD | 0.0% |
2019 Q1 | - CAD | 0.0% |
2019 Q3 | - CAD | 0.0% |
2018 Q2 | - CAD | 0.0% |
2018 Q3 | - CAD | 0.0% |
2018 Q4 | - CAD | 0.0% |
2018 FY | - CAD | 0.0% |
2018 Q1 | - CAD | -100.0% |
2017 Q3 | 26.96 CAD | 0.0% |
2017 Q4 | 333.13 CAD | 1135.63% |
2017 FY | - CAD | 0.0% |
2017 Q1 | - CAD | 0.0% |
2017 Q2 | - CAD | 0.0% |
2016 Q2 | - CAD | 0.0% |
2016 Q1 | - CAD | 0.0% |
2016 Q4 | - CAD | 0.0% |
2016 FY | - CAD | 0.0% |
2016 Q3 | - CAD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
BioMark Diagnostics Inc. | 163.22 Thousand CAD | 100.0% |
Sona Nanotech Inc. | - CAD | NaN% |